Tirzepatide is a dual GIP and GLP1 receptor agonist given as a once-weekly injection that improves insulin response, slows digestion, reduces appetite, and supports significant weight loss when combined with lifestyle changes
Para pacientes con diabetes tipo 2, esto puede incluir optimizacin de otros agentes antidiabticos, intensificacin de modificaciones del estilo de vida, o transicin a terapias alternativas
Potential explanations include the dual receptor agonism of tirzepatide 23
We pair their expertise with our editorial best practices to curate the thoughtful edits you read on our site
\Nerve Support: May promote nerve growth and functional improvement after brain or nerve injury
We urge caution with any supplement particularly those that claim to influence GLP-1 or promote weight loss and recommend discussing any products youre considering with a licensed healthcare provider before use